Natural tumor surveillance capabilities of the host were investigated in six different mouse tumor models where endogenous interleukin (IL)-12 does or does not dictate the efficiency of the innate immune response. Gene-targeted and lymphocyte subset–depleted mice were used to establish the relative importance of natural killer (NK) and NK1.1+ T (NKT) cells in protection from tumor initiation and metastasis. In the models examined, CD3− NK cells were responsible for tumor rejection and protection from metastasis in models where control of major histocompatibility complex class I–deficient tumors was independent of IL-12. A protective role for NKT cells was only observed when tumor rejection required endogenous IL-12 activity. In particular, T cell receptor Jα281 gene-targeted mice confirmed a critical function for NKT cells in protection from spontaneous tumors initiated by the chemical carcinogen, methylcholanthrene. This is the first description of an antitumor function for NKT cells in the absence of exogenously administered potent stimulators such as IL-12 or α-galactosylceramide.
Skip Nav Destination
Article navigation
21 February 2000
Article|
February 21 2000
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Mark J. Smyth,
Mark J. Smyth
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Search for other works by this author on:
Kevin Y. T. Thia,
Kevin Y. T. Thia
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Search for other works by this author on:
Shayna E.A. Street,
Shayna E.A. Street
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Search for other works by this author on:
Erika Cretney,
Erika Cretney
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Search for other works by this author on:
Joseph A. Trapani,
Joseph A. Trapani
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Search for other works by this author on:
Masaru Taniguchi,
Masaru Taniguchi
bDivision of Molecular Immunology, Center of Biomedical Sciences, School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Tetsu Kawano,
Tetsu Kawano
bDivision of Molecular Immunology, Center of Biomedical Sciences, School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Sonja B. Pelikan,
Sonja B. Pelikan
cDepartment of Pathology and Immunology, Monash University Medical School, Prahran, 3181 Victoria, Australia
Search for other works by this author on:
Nadine Y. Crowe,
Nadine Y. Crowe
cDepartment of Pathology and Immunology, Monash University Medical School, Prahran, 3181 Victoria, Australia
Search for other works by this author on:
Dale I. Godfrey
Dale I. Godfrey
cDepartment of Pathology and Immunology, Monash University Medical School, Prahran, 3181 Victoria, Australia
Search for other works by this author on:
Mark J. Smyth
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Kevin Y. T. Thia
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Shayna E.A. Street
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Erika Cretney
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Joseph A. Trapani
aFrom the Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, 3084 Victoria, Australia
Masaru Taniguchi
bDivision of Molecular Immunology, Center of Biomedical Sciences, School of Medicine, Chiba University, Chiba 260-8670, Japan
Tetsu Kawano
bDivision of Molecular Immunology, Center of Biomedical Sciences, School of Medicine, Chiba University, Chiba 260-8670, Japan
Sonja B. Pelikan
cDepartment of Pathology and Immunology, Monash University Medical School, Prahran, 3181 Victoria, Australia
Nadine Y. Crowe
cDepartment of Pathology and Immunology, Monash University Medical School, Prahran, 3181 Victoria, Australia
Dale I. Godfrey
cDepartment of Pathology and Immunology, Monash University Medical School, Prahran, 3181 Victoria, Australia
Abbreviations used in this paper: α-GalCer, α-galactosylceramide(s); B6, C57BL/6; B6.Jα281−/−, TCR Jα281–deficient B6; B6.P−/−, perforin-deficient B6; B6.IL-12p40−/−; IL-12p40–deficient B6; DC, dendritic cell; MCA, methylcholanthrene; NKT cell, NK1.1+ T cell.
Received:
August 25 1999
Revision Requested:
November 22 1999
Accepted:
November 30 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (4): 661–668.
Article history
Received:
August 25 1999
Revision Requested:
November 22 1999
Accepted:
November 30 1999
Citation
Mark J. Smyth, Kevin Y. T. Thia, Shayna E.A. Street, Erika Cretney, Joseph A. Trapani, Masaru Taniguchi, Tetsu Kawano, Sonja B. Pelikan, Nadine Y. Crowe, Dale I. Godfrey; Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells. J Exp Med 21 February 2000; 191 (4): 661–668. doi: https://doi.org/10.1084/jem.191.4.661
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement